Research and Markets: Identify the Key Factors Influencing the NRT Smoking Cessation Aids Market in United States.DUBLIN Dublin, city, Republic of Ireland Dublin, Irish Baile Átha Cliath, county borough (1991 pop. 915,516), Leinster, capital of the Republic of Ireland, on Dublin Bay at the mouth of the Liffey River. , Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c40760) has announced the addition of NRT NRT Nicotine Replacement Therapy NRT Norm-Referenced Test NRT near real time NRT Non-Real-Time NRT National Response Team NRT Tokyo, Japan - Narita (Airport Code) NRT Net Registered Tonnage Smoking Cessation smoking cessation Public health Temporary or permanent halting of habitual cigarette smoking; withdrawal therapies–eg, hypnosis, psychotherapy, group counseling, exposing smokers to Pts with terminal lung CA and nicotine chewing gum are often ineffective. Aids in United States United States, officially United States of America, republic (2005 est. pop. 295,734,000), 3,539,227 sq mi (9,166,598 sq km), North America. The United States is the world's third largest country in population and the fourth largest country in area. to their offering. Our Smoking Cessation Aids in the United States report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data (2000-2005), allowing you to identify the sectors driving growth. It identifies the leading companies, the leading brands and offers strategic analysis of key factors influencing the market - be they new product developments, distribution or pricing issues. Forecasts to 2010 illustrate how the market is set to change. Product coverage: NRT gum, NRT patches, NRT inhalators, other Data coverage: market sizes (historic and forecasts), company shares, brand shares Why buy this report? --Get a detailed picture of the smoking cessation aids industry --Pinpoint growth sectors and trends and identify factors driving change --Understand the competitive environment, the market's major players and leading brands --Use five-year forecasts to assess how the market is predicted to develop With a network of over 600 analysts worldwide, we have a unique capability to develop reliable information resources (1) The data and information assets of an organization, department or unit. See data administration. (2) Another name for the Information Systems (IS) or Information Technology (IT) department. See IT. to help drive informed strategic planning Strategic planning is an organization's process of defining its strategy, or direction, and making decisions on allocating its resources to pursue this strategy, including its capital and people. . Topics Covered: 1. EXECUTIVE SUMMARY 2. OPERATING ENVIRONMENT - 2.1 OTC Registration and Classification - 2.2 Vitamins & Dietary Supplements Registration and Classification - 2.3 Advertising - 2.4 Packaging and Labelling - 2.5 Distribution - 2.6 De-listing or De-reimbursement - 2.7 Traditional Remedies - 2.8 Homeopathy - 2.9 Generics - 2.10 Consumer Expenditure on Health Goods and Medical Services - 2.11 Life Expectancy 3. OTC HEALTHCARE SALES - 3.1 Market Performance - 3.2 Switches - 3.3 Key Trends and Developments - 3.4 Competitive Environment - 3.5 Leading Company Profile: Bayer Corporation - 3.6 Leading Company Profile: GlaxoSmithKline Plc - 3.7 Leading Company Profile: Johnson & Johnson Inc - 3.8 Leading Company Profile: NBTY Inc - 3.9 Leading Company Profile: Novartis AG - 3.10 Leading Company Profile: Pfizer Inc - 3.11 Leading Companies: The Procter & Gamble Company - 3.12 Leading Companies: Schering-Plough Corp - 3.13 Leading Companies: Wyeth - 3.14 Emerging and Niche Companies - 3.15 Retail Distribution - 3.16 Retailer Activity and Private Label Trends - 3.17 Forecast Market Performance 4. NRT SMOKING CESSATION AIDS SALES - 4.1 Number of Smokers - 4.2 Sector Performance - 4.3 New Product Developments 5. DEFINITIONS Summary Market exits as companies focus on Rx business The US OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). healthcare market was a changing landscape in 2005 as Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were and Boots International both decided to exit in order to focus on their prescription drug prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, businesses. Bristol-Myers Squibb sold its US and Canadian Canadian (kənā`dēən), river, 906 mi (1,458 km) long, rising in NE New Mexico. and flowing E across N Texas and central Oklahoma into the Arkansas River in E Oklahoma. consumer health portfolio, including rights to the Excedrin Ex·ced·rin A trademark for an over-the-counter preparation containing acetaminophen alone or combined with caffeine or aspirin or both. Excedrin® , Vagistat Vagistat® Tioconazole, see there and Comtrex brands, to Novartis. Boots International announced the sale of its US OTC healthcare business to Reckitt Benckiser Reckitt Benckiser plc is one of the world's leading manufacturers of cleaning products and a member of the FTSE 100 Index of the largest companies traded on the London Stock Exchange. It is headquartered in the town of Slough just to the west of Greater London. . The deal includes the Clearasil, Nurofen and Strepsils brands. Wyeth also sold its Solgar Vitamin and Herb division to NBTY during 2005. Finally, Pfizer has announced its intention to sell its consumer healthcare division, a move that promises to impact the US OTC healthcare market even more in 2006. These market exits signal a greater trend for pharmaceutical companies to focus on the more profitable prescription drug market at the expense of OTC healthcare innovations, and such transitions of ownership have slowed the pace of new product development and overall growth in OTC healthcare sales. Companies Mentioned Include: - McNeil Consumer & Specialty Pharmaceuticals - Wyeth Consumer Healthcare Inc - Pfizer Consumer Healthcare Ltd - Procter & Gamble Co, The - GlaxoSmithKline Consumer Health - NBTY Inc - Bayer Corp - Novartis Corp - Schering-Plough Healthcare Products Inc - Johnson & Johnson Consumer Products Inc - Pharmavite Corp - General Nutrition Centers Inc - Amway Corp - Herbalife International Inc - Adams Respiratory Therapeutics Inc - Johnson & Johnson-Merck Consumer Pharmaceuticals Co - Mannatech Inc - Forever Living Products LLC - Chattem Inc - Cadbury Adams USA LLC - Rexall Sundown Inc - Advanced Care Products - Nature's Sunshine Products Inc - Bausch & Lomb Inc - Neutrogena Corp - Life Extension Foundation Inc - Tahitian Noni International Inc - Twinlab Corp - Sunrider International Inc - Airborne Inc - Perrigo Co - Bristol-Myers Squibb Co - Weider Nutrition International Inc - Bayer-Roche LLC - General Nutrition Cos Inc - Pharmacia Corp - Whitehall-Robins - Healthcare For more information visit http://www.researchandmarkets.com/reports/c40760 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion